Answers are grounded in this paper and cite their sources.
Analyzes human norovirus GII genetic diversity, suggesting gene exchange shapes outbreaks.
This study analyzed human norovirus genogroup II (GII) strains detected in Gwangju, South Korea, between 2020 and 2024, focusing on genetic diversity and recombination at the ORF1–ORF2 junction involving the RNA-dependent RNA polymerase (RdRp, ORF1) and the major capsid protein VP1 (ORF2). Using year-round surveillance–based clinical samples, the analysis revealed that recombination events near the ORF1–ORF2 junction were a major driver of genotype replacement over time. Multiple recombinant lineages, including GII.4[P16], GII.17[P31], GII.3[P25], and the emergent, rarely reported genotype GII.7[P7], were detected during the study period. Although the RdRp gene is relatively conserved, sequence variation accumulating near the ORF1–ORF2 boundary may facilitate the emergence of new recombinant RdRp–VP1 combinations. These findings indicate that gene exchange at the ORF1–ORF2 junction plays a central role in shaping human norovirus genetic diversity.
No takes yet. Share an insight, caveat, or question.
Mun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: